I. Fouchard‐Hubert

发表

Determination of reliability criteria for liver stiffness evaluation by transient elastography

V. de Lédinghen, S. Bertrais, F. Oberti, 2013, Hepatology.

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Julien Vergniol, Paul Calès, V. de Lédinghen, 2016, Journal of hepatology.

Distribution of total DNA and cccDNA in serum and PBMCs may reflect the HBV immune status in HBsAg+ and HBsAg- patients coinfected or not with HIV or HCV.

I. Chemin, F. Lunel, A. Rousseau, 2013, Clinics and research in hepatology and gastroenterology.

Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen.

X. Causse, Y. Bacq, F. Lunel, 2003, Journal of hepatology.

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.

F. Carrat, C. Michelet, D. Guyader, 2010, Journal of hepatology.

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study

P. Couzigou, P. Marcellin, J. Pawlotsky, 2005, Journal of viral hepatitis.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

M. Van Ranst, J. Izopet, D. Roulot, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.

P. Marcellin, D. Thabut, F. Carrat, 2017, Journal of hepatology.

Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C?

N. Picard, D. Larrey, P. Saulnier, 2016, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy

Julien Vergniol, Christophe Aubé, V. de Lédinghen, 2016, Hepatology.

Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.

S. Chevret, S. Pol, V. Bourcier, 2022, Journal of hepatology.

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

Vincent Leroy, Paul Calès, S. Bertrais, 2011, The American Journal of Gastroenterology.

Radiofrequency ablation of hepatocellular carcinoma: Mono or multipolar?

C. Aubé, F. Oberti, J. Lebigot, 2016, Journal of gastroenterology and hepatology.

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive

V. de Lédinghen, F. Oberti, P. Calès, 2012, Hepatology.

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C

S. Bertrais, C. Brochard, F. Oberti, 2014, Alimentary pharmacology & therapeutics.

Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C

S. Bertrais, F. Oberti, P. Calès, 2011, BMC gastroenterology.

Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non‐alcoholic fatty liver disease from tertiary care centres

P. Gourdy, C. Bureau, J. Selves, 2019, Alimentary pharmacology & therapeutics.

A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis.

V. de Lédinghen, S. Bertrais, R. Anty, 2017, Journal of hepatology.

Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification

V. de Lédinghen, B. le Bail, G. Hunault, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Optimization and robustness of blood tests for liver fibrosis and cirrhosis.

S. Bertrais, F. Oberti, P. Calès, 2010, Clinical biochemistry.

The combination of a blood test and Fibroscan improves the non‐invasive diagnosis of liver fibrosis

V. de Lédinghen, F. Oberti, P. Calès, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Assessment of new hyaluronic acid assays and their impact on FibroMeter scores.

F. Oberti, P. Calès, Y. Gallois, 2011, Clinica chimica acta; international journal of clinical chemistry.

Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.

V. de Lédinghen, S. Pol, N. Kamar, 2018, Kidney international.

Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C

R. Luiz, P. Calès, V. Pannain, 2017, World journal of hepatology.

524 Liver stiffness measurement (LSM) by transient elastography. predictive factors of accuracy, success and reproducibility

P. Calès, A. Konaté, S. Réaud, 2006 .

Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis

Christophe Aubé, Paul Calès, S. Bertrais, 2010, European journal of gastroenterology & hepatology.

Phase 3, Multicenter Open‐Label study to investigate the efficacy of elbasvir and grazoprevir fixed‐dose combination for 8 weeks in treatment‐naïve, HCV GT1b‐infected patients, with non‐severe fibrosis

T. Asselah, D. Samuel, S. Pol, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests

S. Bertrais, F. Oberti, P. Calès, 2017, Journal of gastroenterology and hepatology.

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C

S. Bertrais, Y. Bacq, F. Oberti, 2014, Journal of Gastroenterology.

1048 ACCURACY OF LIVER FIBROSIS CLASSIFICATIONS PROVIDED BY NON-INVASIVE TESTS

S. Bertrais, F. Oberti, P. Calès, 2010 .

Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!

V. de Lédinghen, G. Hunault, F. Oberti, 2019, Clinical and translational gastroenterology.

Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program

F. Carrat, F. Zoulim, D. Guyader, 2015 .

Treatment of ribavirin/interferon‐induced anemia with erythropoietin in patients with hepatitis C

F. Lunel-Fabiani, P. Lafarge, I. Fouchard‐Hubert, 2002, Hepatology.

[The Hepatitis Network in Maine-et-Loire city hospitals: six year follow-up of patients and physicians. Hepatitis Network of Maine-et-Loire].

P. Calès, C. Payan, E. Geagea, 2000, Gastroenterologie clinique et biologique.

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

V. de Lédinghen, S. Bertrais, F. Oberti, 2017 .

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

S. Bertrais, F. Oberti, P. Calès, 2011, The American Journal of Gastroenterology.

Determination of reliability criteria for liver stiffness evaluation by transient elastography

V. de Lédinghen, S. Bertrais, F. Oberti, 2013, Hepatology.

Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis

F. Oberti, P. Calès, Y. Gallois, 2010, European journal of gastroenterology & hepatology.